Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.
about
STK35L1 associates with nuclear actin and regulates cell cycle and migration of endothelial cellsHepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding proteinGene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects.Expression of hepatoma-derived growth factor family members in the adult central nervous system.Expression of hepatoma-derived growth factor in hepatocarcinogenesisHepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factorOverexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancerSolution structure of the PWWP domain of the hepatoma-derived growth factor familyHepatoma-derived growth factor is a neurotrophic factor harbored in the nucleusHepatoma-derived growth factor-related protein-3 interacts with microtubules and promotes neurite outgrowth in mouse cortical neuronsExpression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activityMitotic phosphorylation activates hepatoma-derived growth factor as a mitogen.The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies.Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domainHepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1.Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer.Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex.Gene expression profiling of the hyperplastic growth zones of the late trout embryo myotome using laser capture microdissection and microarray analysis.Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]Novel perspective: focusing on the X chromosome in reproductive cancers.Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor.The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapyThe isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.Hepatoma-derived growth factor and its role in keloid pathogenesis.Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.p53 and the PWWP domain containing effector proteins in chromatin damage repair.Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells.Secretion of hepatoma-derived growth factor is regulated by N-terminal processing.Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.SUMOylation of the hepatoma-derived growth factor negatively influences its binding to chromatin.Cell surface heparan sulfates mediate internalization of the PWWP/HATH domain of HDGF via macropinocytosis to fine-tune cell signalling processes involved in fibroblast cell migration.Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour.
P2860
Q21562117-CCB98AF1-6581-46EA-AC7F-3B29E9388026Q24320054-0104098C-53F8-4B26-AFD7-5C1BFCF0316EQ24815894-91AEA7FC-1630-4BDE-B0C9-334E99A70301Q25255854-89B9B1A0-9C4A-4213-A0A1-839E085C75CAQ28208376-BF0501CB-0356-4B96-BD86-30DA44368290Q28241567-872AF747-AF36-498A-94DF-A08AEEAAE3B1Q28383771-54B2DE64-BD9D-4AE5-9CD2-92D8ED76E1CCQ28506043-199108B4-37B2-410F-A5C7-00847A874572Q28585720-A33C34F8-285D-4C4B-9BDE-BF3B58629AA0Q28590617-61D9D805-052F-46FC-94FD-A197E2576E45Q28593381-94B1F52C-2FD8-44FA-938B-DB4AEB14B98BQ30432341-17F2A09E-8699-4F7A-837B-9BBFC4D66FE0Q31054311-C5A985D4-59A4-4FCB-B1D3-3FB3480FD650Q33304584-914C6683-B7C9-434F-97B5-F284DF5276CAQ33590801-FC0A04AE-6F71-4F6C-A3E9-4FDEF0BAE260Q34052508-1889B17A-F8A8-45D2-938E-519C7D291BA1Q34106493-066F7425-70EF-4CF6-8A83-5DC429421293Q34543829-681F6B0D-3700-4ECD-9D2C-53EDEC916658Q34622626-AC16FF4C-6E8C-49F2-9CB6-59514D0A7D2DQ34639683-B46D557F-0A25-4940-B32F-956D7466F14DQ35553879-A4133CD5-B7A9-4852-B21D-6AD689FC91E2Q35634321-47BB5BD9-9DA4-4FC5-B2BE-BB1F882B3DC1Q36828146-FB11AC11-DA6B-41B4-BD47-BE1F148C7BD1Q36998991-542109E0-E2C0-464B-9D3C-2CBC2C3D530BQ37021772-520362A7-E82B-43A9-896B-99AD826AE97FQ37078506-E2CAF169-B85E-41EC-A850-D5CE56B8A483Q37310602-2CAB9F13-E57C-48FE-B4A3-38F2D8DABC51Q38066416-42217D39-3872-47DE-A5C1-C08AD9E22DFCQ38255171-3A3A1761-A85C-4EC2-BE06-1EF9EADFBDBFQ38859147-6B956085-1CD9-4CE4-ABC6-4F9B4F814CAFQ38952715-69D1FD69-95C4-4B94-9FFD-FED30DA9AAB6Q39121566-EBF81C9A-F2E3-4CA1-965A-E1526C8546D2Q39507533-27E9AE58-B40F-475D-A8F2-3D2E4352AE04Q39630179-34680A10-CB01-4AAD-B136-49BEAF62B1F7Q39692289-78E2E8AD-DB1C-42D0-8BB3-7EB81AF696BBQ41129159-0FE55D4D-EFC1-467B-B40C-6D2F4FF64045Q42525606-B9A10493-DA54-4E86-93A5-A7B02F2E94CFQ42819181-4BC5E681-8B51-4F02-A7DF-EF450D57F845Q42833272-1604A80A-5977-4CD1-9981-C0A32F6724C4Q44832395-9AE0D8B1-87B3-4E2A-92F3-47CC8AEC2F0E
P2860
Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nuclear targeting is required ...... vascular smooth muscle cells.
@ast
Nuclear targeting is required ...... vascular smooth muscle cells.
@en
type
label
Nuclear targeting is required ...... vascular smooth muscle cells.
@ast
Nuclear targeting is required ...... vascular smooth muscle cells.
@en
prefLabel
Nuclear targeting is required ...... vascular smooth muscle cells.
@ast
Nuclear targeting is required ...... vascular smooth muscle cells.
@en
P2093
P2860
P356
P1476
Nuclear targeting is required ...... vascular smooth muscle cells.
@en
P2093
P2860
P304
37564-37568
P356
10.1074/JBC.M105109200
P407
P577
2001-07-31T00:00:00Z